Forwarded from CRAIG KELLY - Keeping the bastards honest.
Dr. Pierre Kory : “Ivermectin is up against the $100 billion vaccine industry. Ivermectin has the capacity to kneecap the entire vaccine industry ‘’
The War against Ivermectin is the greatest anti-competitive ploy in the history of global commerce. Those deploying anti-competitive practices to suppress Ivermectin (so they can profit from vaccine sales) deserve to spend the rest of their lives in jail, and then rot in hell for eternity.
https://m.youtube.com/watch?v=JESrh_2KOzo&feature=youtu.be
The War against Ivermectin is the greatest anti-competitive ploy in the history of global commerce. Those deploying anti-competitive practices to suppress Ivermectin (so they can profit from vaccine sales) deserve to spend the rest of their lives in jail, and then rot in hell for eternity.
https://m.youtube.com/watch?v=JESrh_2KOzo&feature=youtu.be
"Ayurvedic medicines, especially Ashwagandha (Withania somnifera (L.) Dunal, WS), may be beneficial in the management of COVID-19. WS is a widely prescribed Ayurvedic botanical known as an immunomodulatory, antiviral, anti-inflammatory, and adaptogenic agent. The chemical profile and pharmacological activities of WS have been extensively reported. Several clinical studies have reported its safety for use in humans. This review presents a research synthesis of in silico, in vitro, in vivo, and clinical studies on Withania somnifera (L.) Dunal (WS) and discusses its potential for prophylaxis and management of COVID-19. We have collated the data from studies on WS that focused on viral infections (HIV, HSV, H1N1 influenza, etc.) and noncommunicable diseases (hypertension, diabetes, cancer, etc.). The experimental literature indicates that WS has the potential for 1) maintaining immune homeostasis, 2) regulating inflammation, 3) suppressing pro-inflammatory cytokines, 4) organ protection (nervous system, heart, lung, liver, and kidney), and 5) anti-stress, antihypertensive, and antidiabetic activities. Using these trends, the review presents a triangulation of Ayurveda wisdom, pharmacological properties, and COVID-19 pathophysiology ranging from viral entry to end-stage acute respiratory distress syndrome (ARDS). The review proposes WS as a potential therapeutic adjuvant for various stages of COVID-19 management. WS may also have beneficial effects on comorbidities associated with the COVID-19. However, systematic studies are needed to realize the potential of WS for improving clinical outcome of patients with COVID-19.
The study of literature suggests that WS has important molecular and pharmacological characteristics to act as a therapeutic adjuvant for prophylaxis and treatment of COVID-19. Therefore, WS may synergistically improve the clinical outcomes of COVID-19 pharmacotherapeutics in current use."
https://www.frontiersin.org/articles/10.3389/fphar.2021.623795/full
The study of literature suggests that WS has important molecular and pharmacological characteristics to act as a therapeutic adjuvant for prophylaxis and treatment of COVID-19. Therefore, WS may synergistically improve the clinical outcomes of COVID-19 pharmacotherapeutics in current use."
https://www.frontiersin.org/articles/10.3389/fphar.2021.623795/full
Frontiers
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
As the COVID-19 pandemic is progressing, the therapeutic gaps in conventional management have highlighted the need for the integration of traditional knowledge systems with modern medicine. Ayurvedic medicines, especially Ashwagandha (Withania somnifera (L.)…